The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $2.97

Today's change0.00 0.00%
Updated August 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $2.97

Today's change0.00 0.00%
Updated August 24 4:00 PM EDT. Delayed by at least 15 minutes.

ImmunoGen Inc closed at (U.S.)$2.97.

Over the last five days, shares have lost 4.19% and are down 78.11% for the last year to date. This security has underperformed the S&P 500 by 91.69% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $2.97
  • High--
  • Low--
  • Bid / Ask(U.S.) $0.00 / (U.S.) $3.32
  • YTD % change-78.11%
  • Volume0
  • Average volume (10-day)1,089,552
  • Average volume (1-month)1,269,377
  • Average volume (3-month)1,969,542
  • 52-week range(U.S.) $2.53 to (U.S.) $16.59
  • Beta1.81
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.65
Updated August 24 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue7201815
Total other revenue--------
Total revenue7201815
Gross profit--------
Total cost of revenue--------
Total operating expense47474643
Selling / general / administrative91188
Research & development37363835
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-39-28-28-29
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-45-32-33-34
Income after tax-45-32-33-34
Income tax, total--------
Net income-45-32-33-34
Total adjustments to net income--------
Net income before extra. items-45-32-33-34
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-45-32-33-34
Inc. avail. to common incl. extra. items-45-32-33-34
Diluted net income-45-32-33-34
Dilution adjustment--------
Diluted weighted average shares87878787
Diluted EPS excluding extraordinary itemsvalue per share-0.51-0.37-0.38-0.39
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.51-0.37-0.38-0.39